Optimi Health Corp. (CSE:OPTI)

Market Cap	16.43M
Revenue (ttm)	495.83K
Net Income (ttm)	-4.81M
Shares Out	96.64M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	160,582
Average Volume	46,951
Open	0.1550
Previous Close	0.1600
Day's Range	0.1550 - 0.1700
52-Week Range	0.1050 - 0.3800
Beta	1.02
RSI	57.27
Earnings Date	Aug 29, 2025

About Heartland Financial USA

Optimi Health Corp. produces and supplies psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of manufacturing of drug products. It sells its products through Amazon marketplace and distributors/brokers, as well as online. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. The company was incorporated in 2020 and is ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OPTI

Financial Performance

In 2024, Optimi Health's revenue was 389,850, an increase of 115.28% compared to the previous year's 181,087. Losses were -6.04 million, 16.2% more than in 2023.